Figure. 2

Kaplan–Meier survival curves to reveal the impact on the incidence of thrombocytopenia. (A) Renal replacement therapy (RRT). (B) Fluconazole. Difference between groups were tested by log-rank test. Patients who received RRT (log-rank test P = 0.043) or fluconazole treatment (log-rank test P = 0.0332) showed significantly higher risk of developing linezolid-associated thrombocytopenia.